Circadian genes like PER1 and BMAL1, involved in DNA damage response, may exhibit altered expression in SCLC, potentially affecting the tumor’s response to therapeutic interventions such as radiation and chemotherapy, both of which interact with the circadian control of cell cycle and apoptosis [203]. The gene discussed is PER1; the disease is neoplasm.